Cargando…

Evaluating adverse events in databases

Detalles Bibliográficos
Autores principales:	Lovell, Katie, Feldman, Steven R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10433453/ https://www.ncbi.nlm.nih.gov/pubmed/37589317 http://dx.doi.org/10.1002/prp2.1129

Ejemplares similares

Response to “Evaluating Adverse Events in Databases”
por: Calapai, Fabrizio, et al.
Publicado: (2023)

Adverse Events by Sedation Type in Gastrointestinal Endoscopy
por: Kim, Joon Sung, et al.
Publicado: (2017)

Podcast on the Management of Adverse Events Associated with Lorlatinib
por: Bauer, Todd M., et al.
Publicado: (2022)

Adverse Drug Events in the Elderly: An Ongoing Problem
por: Gray, Charnelda, et al.
Publicado: (2009)

Inappropriate prescribing and adverse drug events in older people
por: Hamilton, Hilary J, et al.
Publicado: (2009)

Serious adverse events associated with yellow fever vaccine
por: de Menezes Martins, Reinaldo, et al.
Publicado: (2015)

Adverse events and nocebo phenomena: treatment or disease specific?
por: Zis, Panagiotis, et al.
Publicado: (2019)

Microbiome transplantation and modulation of immune related adverse events
por: Smibert, Olivia C., et al.
Publicado: (2019)

Adverse Ocular Events following COVID-19 Vaccination
por: Eleiwa, Taher K., et al.
Publicado: (2021)

Methods for safety and endpoint ascertainment: identification of adverse events through scrutiny of negatively adjudicated events
por: Fanaroff, Alexander C., et al.
Publicado: (2020)

Immune‐Related Adverse Events in the Setting of PD‐1/L1 Inhibitor Combination Therapy
por: Zubiri, Leyre, et al.
Publicado: (2019)

Cosmetics and Cancer: Adverse Event Reports Submitted to the Food and Drug Administration
por: Jacob, Saya L, et al.
Publicado: (2018)

Hepatitis B vaccine adverse events in China: Risk control and regulation
por: Meina, Li, et al.
Publicado: (2014)

Inflammatory Arthritis: A Newly Recognized Adverse Event of Immune Checkpoint Blockade
por: Naidoo, Jarushka, et al.
Publicado: (2017)

Evaluating Chemicals for Thyroid Disruption: Opportunities and Challenges with in Vitro Testing and Adverse Outcome Pathway Approaches
por: Noyes, Pamela D., et al.
Publicado: (2019)

IL‐7 germline variant: setting the stage for immune‐related adverse events
por: Issaoui, Hussein, et al.
Publicado: (2023)

Comprehensive Assessment of Serious Adverse Events Following Immunization by Health Care Providers
por: Williams, S. Elizabeth, et al.
Publicado: (2013)

General determination of causation between Covid-19 vaccines and possible adverse events
por: Hampton, Lee M., et al.
Publicado: (2021)

Adverse Events with Amiodarone—Will the List Ever End?
por: Reiffel, James A.
Publicado: (2018)

Association of immune-related adverse events with immune checkpoint inhibitor efficacy: real or imaginary?
por: Haratani, Koji, et al.
Publicado: (2020)

A Test Identifying Biomarkers of Immunosuppression-Related Adverse Events in Kidney Transplant Recipients
por: Legendre, Christophe
Publicado: (2019)

Commentary: Adapting for our patients: Reducing intraoperative adverse events as new technologies emerge
por: Yan, Weiang, et al.
Publicado: (2020)

Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database
por: Nagai, Junko, et al.
Publicado: (2021)

Assessing taxane-associated adverse events using the FDA adverse event reporting system database
por: Lao, Dong-Hui, et al.
Publicado: (2021)

Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database
por: Yamashiro, Kaito, et al.
Publicado: (2022)

Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: the role of kidney
por: Giugliano, Dario, et al.
Publicado: (2020)

Categorisation of Pharmaceutical Adverse Events Using the Japanese Adverse Drug Event Report Database: Characteristic Adverse Drug Events of the Elderly Treated with Polypharmacy
por: Negishi, Akio, et al.
Publicado: (2020)

Characteristics of Adverse Events Following Immunization Reporting in Children: The Japanese Adverse Drug Event Report Database
por: Noda, Aoi, et al.
Publicado: (2020)

Visualization of Kinase Inhibition-Related Adverse Events Using the Japanese Adverse Drug Event Report Database
por: Mizuno, Takahito, et al.
Publicado: (2021)

Database of adverse events associated with drugs and drug combinations
por: Poleksic, Aleksandar, et al.
Publicado: (2019)

Epigenetic Applications in Adverse Outcome Pathways and Environmental Risk Evaluation
por: Angrish, Michelle M., et al.
Publicado: (2018)

Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies
por: Kerepesi, Csaba, et al.
Publicado: (2020)

Potential adverse events in Japanese women who received tozinameran (BNT162b2, Pfizer-BioNTech)
por: Shimazawa, Rumiko, et al.
Publicado: (2021)

Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database
por: Lehrer, Steven, et al.
Publicado: (2018)

Adverse Events Associated with Fosfomycin Use: Review of the Literature and Analyses of the FDA Adverse Event Reporting System Database
por: Iarikov, Dmitri, et al.
Publicado: (2015)

Rechallenge patients with immune checkpoint inhibitors following severe immune-related adverse events: review of the literature and suggested prophylactic strategy
por: Haanen, John, et al.
Publicado: (2020)

Adverse Childhood Event Scores Associated With Likelihood of Missing Appointments and Unsuppressed HIV in a Southeastern U.S. Urban Clinic Sample
por: Campbell, Kari, et al.
Publicado: (2019)

Exploring the feasibility of integration of surveillance for intussusception into the routine monitoring of adverse events following immunization by countries of the WHO African Region for Africa
por: Mpabalwani, Evans Mwila, et al.
Publicado: (2022)

Evaluation of Dabigatran- and Warfarin-Associated Hemorrhagic Events Using the FDA-Adverse Event Reporting System Database Stratified by Age
por: ABE, Junko, et al.
Publicado: (2015)

Reply to Retrospective evaluation of cetuximab-related adverse events from claims databases—methodological concerns
por: Foley, K. A., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_a9ocefqqi638c8j25356tc09br